Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients
Cells · 2023
DOI: 10.3390/cells12152002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Alexandra E Butler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Royal College of Surgeons in Ireland Bahrain, Busaiteen P.O. Box 15503, Adliya, Bahrain. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Obesity, Complement System Proteins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Upregulation of complement system factors are reported to be increased in polycystic ovary syndrome (PCOS) and may be due to obesity and insulin resistance rather than inherently due to PCOS. We directly compared complement factors from an obese, insulin-resistant PCOS population to a nonobese, non-insulin-resistant PCOS population in a proteomic analysis to investigate this.
Methods
Plasma was collected from 234 women (137 with PCOS and 97 controls) from a biobank cohort and compared to a nonobese, non-insulin-resistant population (24 with PCOS and 24 controls). Slow off-rate modified aptamer (SOMA) scan plasma protein measurement was undertaken for the following complement system proteins: C1q, C1r, C2, C3, C3a, iC3b, C3b, C3d, C3adesArg, C4, C4a, C4b, C5, C5a, C5b-6 complex, C8, properdin, factor B, factor D, factor H, factor I, Mannose-binding protein C (MBL), complement decay-accelerating factor (DAF) and complement factor H-related protein 5 (CFHR5).
Results
The alternative pathway of the complement system was overexpressed in both obese and nonobese PCOS, with increased C3 (p < 0.05) and properdin (p < 0.01); additionally, factor B increased in obese PCOS (p < 0.01). For inhibitors of this pathway, factor I was increased (p < 0.01) in both slim and obese PCOS, with an increase in CFHR5 and factor H in obese PCOS (p < 0.01). Complement factors iC3b, C3d and C5a, associated with an enhanced B cell response and inflammatory cytokine release, were increased in both slim and obese PCOS (p < 0.05). C3a and its product, C3adesArg, were both significantly elevated in nonobese PCOS (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Royal College of Surgeons in Ireland Bahrain, Busaiteen P.O. Box 15503, Adliya, Bahrain.
- Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull HU6 7RU, UK.
ORCID-Profile: Thozhukat Sathyapalan, Stephen L Atkin
Zitieren
APA
Butler, A. E., Moin, A. S. M., Sathyapalan, T., & Atkin, S. L. (2023). Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients. Cells. https://doi.org/10.3390/cells12152002
Vancouver
Butler AE, Moin ASM, Sathyapalan T, Atkin SL. Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients. Cells. 2023. doi:10.3390/cells12152002
BibTeX
@article{Butler2023,
author = {Butler, Alexandra E and Moin, Abu Saleh Md and Sathyapalan, Thozhukat and Atkin, Stephen L},
title = {Complement Dysregulation in Obese Versus Nonobese Polycystic Ovary Syndrome Patients},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12152002}
}
EUVIMED